Sale!

Liver Fibrosis Panel Test Cost

Original price was: 430 د.إ.Current price is: 390 د.إ.

-9%

The Liver Fibrosis Panel Test is a comprehensive diagnostic tool used to assess the extent of fibrosis or scarring in the liver. This non-invasive test is crucial for evaluating the progression of liver diseases, such as hepatitis C, hepatitis B, and non-alcoholic fatty liver disease (NAFLD), among others. By measuring specific biomarkers in the blood, the test can provide valuable information on the liver’s condition, helping healthcare professionals determine the most appropriate treatment plan.

At DNA Labs UAE, the Liver Fibrosis Panel Test is available for 390 AED. This state-of-the-art facility is equipped with the latest in diagnostic technology, ensuring accurate and reliable results. The test is performed by skilled professionals who specialize in advanced diagnostic services, making DNA Labs UAE a preferred choice for individuals seeking comprehensive liver health assessments.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

LIVER FIBROSIS PANEL Test

At DNA Labs UAE, we offer the LIVER FIBROSIS PANEL test to assess the degree of liver fibrosis. Liver fibrosis is the excessive accumulation of scar tissue in the liver, and this test helps in evaluating the severity of liver damage and determining the appropriate treatment approach.

Test Components

  • AST (SGOT)
  • ALT (SGPT)
  • GGTP
  • Bilirubin
  • Protein, Total
  • Alkaline Phosphatase
  • Prothrombin time
  • Protein Electrophoresis, Serum

Price

AED 390.0

Sample Condition

3 mL (2 mL min.) serum from 1 SST AND 3 mL whole blood in 1 Blue Top (Sodium Citrate) tube. Mix thoroughly by inversion. Transport to Lab within 4 hours. If this is not possible, make PPP within 1 hour of collection as follows: Centrifuge sample at 3600 rpm for 15 min. & transfer supernatant to a clean plastic tube. Centrifuge this supernatant again at 3600 rpm for 15 mins. & finally transfer the supernatant (PPP) to 1 labelled, clean plastic screw capped vial. FREEZE IMMEDIATELY. Ship frozen. DO NOT THAW. Overnight fasting is preferred. Duly filled Coagulation Requisition Form (Form 15) is mandatory.

Report Delivery

Sample Daily by 9 am; Report Same Day

Method

Spectrophotometry, Electromechanical Clot Detection, Capillary Electrophoresis

Test Type

Disorders of Liver

Doctor

Gastroenterologist

Test Department

Pre Test Information

Overnight fasting is preferred. It is recommended that the patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. Duly filled Coagulation Requisition Form (Form 15) is mandatory.

Test Details

The LIVER FIBROSIS PANEL test is a diagnostic tool used to assess the degree of liver fibrosis, which is the excessive accumulation of scar tissue in the liver. This test helps in evaluating the severity of liver damage and determining the appropriate treatment approach.

The panel typically includes several biomarkers that are associated with liver fibrosis, such as:

  1. FibroTest: This blood test measures the levels of various proteins and enzymes, including alpha-2-macroglobulin, haptoglobin, apolipoprotein A1, gamma-glutamyl transpeptidase, and bilirubin. The results are combined to calculate a FibroTest score, which indicates the degree of fibrosis.
  2. FibroScan: This non-invasive imaging technique uses ultrasound waves to measure the liver’s stiffness. Higher stiffness indicates more advanced fibrosis.
  3. Enhanced Liver Fibrosis (ELF) test: This test measures three biomarkers – hyaluronic acid, tissue inhibitor of metalloproteinase 1, and amino-terminal propeptide of type III procollagen. The results are combined to provide an ELF score, which correlates with the severity of fibrosis.
  4. AST to Platelet Ratio Index (APRI): This simple blood test calculates the ratio of the liver enzyme aspartate aminotransferase (AST) to the platelet count. Higher ratios indicate more severe fibrosis.

By combining the results of these tests, healthcare providers can assess the degree of liver fibrosis and determine the appropriate treatment plan, including lifestyle changes, medication, or liver transplantation if necessary.

Test Name LIVER FIBROSIS PANEL Test
Components *AST (SGOT)*ALT (SGPT)*GGTP*Bilirubin *Protein, Total*Alkaline Phosphatase *Prothrombin time*Protein Electrophoresis, Serum
Price 390.0 AED
Sample Condition 3 mL (2 mL min.) serum from 1 SST AND 3 mL whole blood in 1 Blue Top (Sodium Citrate) tube. Mix thoroughly by inversion. Transport to Lab within 4 hours. If this is not possible, make PPP within 1 hour of collection as follows: Centrifuge sample at 3600 rpm for 15 min. & transfer supernatant to a clean plastic tube. Centrifuge this supernatant again at 3600 rpm for 15 mins. & finally transfer the supernatant (PPP) to 1 labelled, clean plastic screw capped vial. FREEZE IMMEDIATELY. Ship frozen. DO NOT THAW. Overnight fasting is preferred. Duly filled Coagulation Requisition Form (Form 15) is mandatory.
Report Delivery Sample Daily by 9 am; Report Same Day
Method Spectrophotometry, Electromechanical Clot Detection, Capillary Electrophoresis
Test type Disorders of Liver
Doctor Gastroenterologist
Test Department:
Pre Test Information Overnight fasting is preferred. It is recommended that patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. Duly filled Coagulation Requisition Form (Form 15) is mandatory.
Test Details

The LIVER FIBROSIS PANEL test is a diagnostic tool used to assess the degree of liver fibrosis, which is the excessive accumulation of scar tissue in the liver. This test helps in evaluating the severity of liver damage and determining the appropriate treatment approach.

The panel typically includes several biomarkers that are associated with liver fibrosis, such as:

1. FibroTest: This blood test measures the levels of various proteins and enzymes, including alpha-2-macroglobulin, haptoglobin, apolipoprotein A1, gamma-glutamyl transpeptidase, and bilirubin. The results are combined to calculate a FibroTest score, which indicates the degree of fibrosis.

2. FibroScan: This non-invasive imaging technique uses ultrasound waves to measure the liver’s stiffness. Higher stiffness indicates more advanced fibrosis.

3. Enhanced Liver Fibrosis (ELF) test: This test measures three biomarkers – hyaluronic acid, tissue inhibitor of metalloproteinase 1, and amino-terminal propeptide of type III procollagen. The results are combined to provide an ELF score, which correlates with the severity of fibrosis.

4. AST to Platelet Ratio Index (APRI): This simple blood test calculates the ratio of the liver enzyme aspartate aminotransferase (AST) to the platelet count. Higher ratios indicate more severe fibrosis.

By combining the results of these tests, healthcare providers can assess the degree of liver fibrosis and determine the appropriate treatment plan, including lifestyle changes, medication, or liver transplantation if necessary.